Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2011, Article ID 835932, 11 pages
http://dx.doi.org/10.1155/2011/835932
Research Article

Alteration of the Cardiac Sympathetic Innervation Is Modulated by Duration of Diabetes in Female Rats

1Department of Physiology, Faculty of Medicine in Plzeň, Charles University, Lidická 1, 301 00 Plzeň, Czech Republic
2Department of Histology and Embryology, Faculty of Medicine in Plzeň, Charles University, Karlovarská 48, 301 00 Plzeň, Czech Republic

Received 20 December 2010; Accepted 13 May 2011

Academic Editor: Bernard Portha

Copyright © 2011 Jitka Švíglerová et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. I. Vinik, R. Freeman, and T. Erbas, “Diabetic autonomic neuropathy,” Seminars in Neurology, vol. 23, no. 4, pp. 365–372, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. D. W. Bergner and J. J. Goldberger, “Diabetes mellitus and sudden cardiac death: what are the data?” Cardiology Journal, vol. 17, no. 2, pp. 117–129, 2010. View at Google Scholar · View at Scopus
  3. J. Hilsted, “Catecholamines and diabetic autonomic neuropathy,” Diabetic Medicine, vol. 12, no. 4, pp. 296–297, 1995. View at Google Scholar · View at Scopus
  4. E. Heyman, P. Delamarche, P. Berthon et al., “Alteration insympathoadrenergic activity at rest andduring intense exercise despite normal aerobic fitness inlate pubertal adolescent girls with type 1diabetes,” Diabetes and Metabolism, vol. 33, no. 6, pp. 422–429, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Esler, G. Jennings, G. Lambert, I. Meredith, M. Horne, and G. Eisenhofer, “Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions,” Physiological Reviews, vol. 70, no. 4, pp. 963–985, 1990. View at Google Scholar · View at Scopus
  6. G. Eisenhofer, M. D. Esler, H. S. Cox et al., “Differences in the neuronal removal of circulating epinephrine and norepinephrine,” Journal of Clinical Endocrinology and Metabolism, vol. 70, no. 6, pp. 1710–1720, 1990. View at Google Scholar · View at Scopus
  7. D. S. Goldstein, R. O. Cannon, A. Quyyumi et al., “Regional extraction of circulating norepinephrine, DOPA, and dihydroxyphenylglycol in humans,” Journal of the Autonomic Nervous System, vol. 34, no. 1, pp. 17–36, 1991. View at Publisher · View at Google Scholar · View at Scopus
  8. P. K. Ganguly, K. S. Dhalla, and I. R. Innes, “Altered norepinephrine turnover and metabolism in diabetic cardiomyopathy,” Circulation Research, vol. 59, no. 6, pp. 684–693, 1986. View at Google Scholar · View at Scopus
  9. P. W. F. Wilson, “Diabetes mellitus and coronary heart disease,” American Journal of Kidney Diseases, vol. 32, no. 5, supplement 3, pp. S89–S100, 1998. View at Google Scholar · View at Scopus
  10. H. Colhoun, “Coronary heart disease in women: why the disproportionate risk?” Current Diabetes Reports, vol. 6, no. 1, pp. 22–28, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Kuncová, J. Švíglerová, Z. Tonar, and J. Slavíková, “Heterogenous changes in neuropeptide Y, norepinephrine and epinephrine concentrations in the hearts of diabetic rats,” Autonomic Neuroscience, vol. 121, no. 1–2, pp. 7–15, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Garofano, P. Czernichow, and B. Breant, “Impaired β-cell regeneration in perinatally malnourished rats: a study with STZ,” The Federation of American Societies for Experimental Biology Journal, vol. 14, no. 15, pp. 2611–2617, 2000. View at Google Scholar · View at Scopus
  13. E. N. Su, V. A. Alder, D. Y. Yu, P. K. Yu, S. J. Cringle, and K. Yogesan, “Continued progression of retinopathy despite spontaneous recovery to normoglycemia in a long-term study of streptozotocin-induced diabetes in rats,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 238, no. 2, pp. 163–173, 2000. View at Google Scholar · View at Scopus
  14. A. A. Rossini, R. M. Williams, M. C. Appel, and A. A. Like, “Sex differences in the multiple-dose streptozotocin model of diabetes,” Endocrinology, vol. 103, no. 4, pp. 1518–1520, 1978. View at Google Scholar · View at Scopus
  15. E. H. Leiter, “Multiple low-dose streptozotocin-induced hyperglycemia and insulitis in C57BL mice: influence of inbred background, sex, and thymus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 79, no. 2, pp. 630–634, 1982. View at Google Scholar · View at Scopus
  16. K. K. Hicks, E. Seifen, J. R. Stimers, and R. H. Kennedy, “Effects of streptozotocin-induced diabetes on heart rate, blood pressure and cardiac autonomic nervous control,” Journal of the Autonomic Nervous System, vol. 69, no. 1, pp. 21–30, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. A. M. W. Alings and L. N. Bouman, “Electrophysiology of the ageing rabbit and cat sinoatrial node: a comparative study,” European Heart Journal, vol. 14, no. 9, pp. 1278–1288, 1993. View at Google Scholar · View at Scopus
  18. H. Dobrzynski, M. R. Boyett, and R. H. Anderson, “New insights into pacemaker activity: promoting understanding of sick sinus syndrome,” Circulation, vol. 115, no. 14, pp. 1921–1932, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. S. A. Jones, M. R. Boyett, and M. K. Lancaster, “Declining into failure: the age-dependent loss of the L-type calcium channel within the sinoatrial node,” Circulation, vol. 115, no. 10, pp. 1183–1190, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. D. D. Christou and D. R. Seals, “Decreased maximal heart rate with aging is related to reduced β-adrenergic responsiveness but is largely explained by a reduction in intrinsic heart rate,” Journal of Applied Physiology, vol. 105, no. 1, pp. 24–29, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. F. C. Howarth, N. Nowotny, E. Zilahi, M. A. El Haj, and M. Lei, “Altered expression of gap junction connexin proteins may partly underlie heart rhythm disturbances in the streptozotocin-induced diabetic rat heart,” Molecular and Cellular Biochemistry, vol. 305, no. 1–2, pp. 145–151, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. C. F. Howarth, R. Al-Sharhan, A. Al-Hammadi, and M. A. Qureshi, “Effects of streptozotocin-induced diabetes on action potentials in the sinoatrial node compared with other regions of the rat heart,” Molecular and Cellular Biochemistry, vol. 300, no. 1–2, pp. 39–46, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Linnemann and H. U. Janka, “Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen diabetes study,” Experimental and Clinical Endocrinology and Diabetes, vol. 111, no. 4, pp. 215–222, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. J. A. Larsen and A. H. Kadish, “Effects of gender on cardiac arrhythmias,” Journal of Cardiovascular Electrophysiology, vol. 9, no. 6, pp. 655–667, 1998. View at Google Scholar · View at Scopus
  25. T. V. Pham and M. R. Rosen, “Sex, hormones, and repolarization,” Cardiovascular Research, vol. 53, no. 3, pp. 740–751, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Cheng, “Evidences of the gender-related differences in cardiac repolarization and the underlying mechanisms in different animal species and human,” Fundamental and Clinical Pharmacology, vol. 20, no. 1, pp. 1–8, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Y. Felten, R. G. Peterson, P. A. Shea, H. R. Besch Jr., and D. L. Felten, “Effects of streptozotocin diabetes on the noradrenergic innervation of the rat heart: a longitudinal histofluorescence and neurochemical study,” Brain Research Bulletin, vol. 8, no. 6, pp. 593–607, 1982. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Yoshida, H. Nishioka, Y. Nakamura, and M. Kondo, “Reduced noradrenaline turnover in streptozotocin-induced diabetic rats,” Diabetologia, vol. 28, no. 9, pp. 692–696, 1985. View at Google Scholar · View at Scopus
  29. N. Akiyama, K. Okumura, Y. Watanabe et al., “Altered acethlcholine and norepinephrine concentrations in diabetic rat hearts. Role of parasympathetic nervous system in diabetic cardiomyopathy,” Diabetes, vol. 38, no. 2, pp. 231–236, 1989. View at Google Scholar · View at Scopus
  30. P. K. Ganguly, R. E. Beamish, K. S. Dhalla, I. R. Innes, and N. S. Dhalla, “Norepinephrine storage, distribution, and release in diabetic cardiomyopathy,” American Journal of Physiology, vol. 252, no. 6, pp. E734–E739, 1987. View at Google Scholar · View at Scopus
  31. S. Gando, Y. Hattori, and M. Kanno, “Altered cardiac adrenergic neurotransmission in streptozotocin-induced diabetic rats,” British Journal of Pharmacology, vol. 109, no. 4, pp. 1276–1281, 1993. View at Google Scholar · View at Scopus
  32. D. L. Snyder, V. J. Aloyo, W. Wang, and J. Roberts, “Influence of age and dietary restriction on norepinephrine uptake into cardiac synaptosomes,” Journal of Cardiovascular Pharmacology, vol. 32, no. 6, pp. 896–901, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Takenouchi, T. Kobayashi, K. Taguchi, T. Matsumoto, and K. Kamata, “Gender differences in vascular reactivity of aortas from streptozotocin-induced diabetic mice,” Biological and Pharmaceutical Bulletin, vol. 33, no. 10, pp. 1692–1697, 2010. View at Google Scholar · View at Scopus
  34. J. Kuncová, J. Slavíková, and J. Švíglerová, “Norepinephrine release in the heart atria of diabetic rats,” General Physiology and Biophysics, vol. 22, no. 3, pp. 397–410, 2003. View at Google Scholar
  35. U. Trendelenburg, “Carrier-mediated outward transport of noradrenaline from adrenergic varicosities,” Polish Journal of Pharmacology and Pharmacy, vol. 42, no. 6, pp. 515–520, 1990. View at Google Scholar · View at Scopus
  36. Y. Kiyono, S. Kajiyama, H. Fujiwara, N. Kanegawa, and H. Saji, “Influence of the polyol pathway on norepinephrine transporter reduction in diabetic cardiac sympathetic nerves: implications for heterogeneous accumulation of MIBG,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 32, no. 8, pp. 993–997, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Zugck, D. Lossnitzer, J. Backs, A. Kristen, R. Kinscherf, and M. Haass, “Increased cardiac norepinephrine release in spontaneously hypertensive rats: role of presynaptic alpha-2A adrenoceptors,” Journal of Hypertension, vol. 21, no. 7, pp. 1363–1369, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. D. Richardt, A. Dendorfer, R. Tölg, P. Dominiak, and G. Richardt, “Inhibition of nonexocytotic norepinephrine release by desipramine reduces myocardial infarction size,” Canadian Journal of Physiology and Pharmacology, vol. 84, no. 11, pp. 1185–1189, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Langeloh, H. Bonisch, and U. Trendelenburg, “The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake1: multifactorial induction of outward transport,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 336, no. 6, pp. 602–610, 1987. View at Google Scholar · View at Scopus
  40. G. Levi and M. Raiteri, “Carrier-mediated release of neurotransmitters,” Trends in Neurosciences, vol. 16, no. 10, pp. 415–419, 1993. View at Publisher · View at Google Scholar · View at Scopus
  41. V. Javorková, L. Mézešová, J. Vlkovičová, and N. Vrbjar, “Influence of sub-chronic diabetes mellitus on functional properties of renal Na(+),K(+)-ATPase in both genders of rats,” General Physiology and Biophysics, vol. 29, no. 3, pp. 266–274, 2010. View at Publisher · View at Google Scholar · View at Scopus